ARTICLE
|
doi:10.20944/preprints202108.0289.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
bortezomib; cMAF; MAFb; multiple myeloma; POMP; prognosis; PFS; survival; OS
Online: 13 August 2021 (08:43:42 CEST)